Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study.

NCT04707326 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04707326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04707326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study.
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2019
Completion date
November 1, 2026
Enrollment
2,040 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hiv